Zhao et al. demonstrated that reduced miR-3188 was an unfavorable factor in nasopharyngeal carcinoma (NPC) clinical samples and that miR-3188 directly targeted mTOR and mediated NPC cell growth, tumorigenesis and chemotherapy resistance [34]. This evidence concerns the gene MTOR and nasopharyngeal carcinoma.